Extract of Ginkgo biloba exacerbates liver metastasis in a mouse colon cancer Xenograft model

Huan Wang, Xia Wu, Stephane Lezmi, Qian Li, William G. Helferich, Yueqing Xu, Hong Chen

Research output: Contribution to journalArticle

Abstract

Background: Metastasis refers to the spread of a primary tumor cell from the primary site to other locations in the body and it is generally associated with the severity of a tumor. Extract of Ginkgo biloba (EGb) contains various bioactive compounds and it exerts beneficial effects including improvements in brain function and reduced risk of cardiovascular diseases. On the other hand, increased risk of thyroid and liver cancers by EGb have been reported in animals. Methods: A colon cancer metastasis model was established using intrasplenic injection of a human colon cancer cell line, SW620-luc in athymic mice to investigate the potential impact of EGb on colon cancer progression. After tumor establishment, EGb was intraperitonically injected daily for 5 wks. Results: EGb significantly increased the rate of metastasis in mouse liver and decreased the number of necrotic and apoptotic cells in the metastatic liver when compared to the control. Meanwhile, EGb significantly induced proliferation of tumor cells in the metastatic liver, indicated by increased staining of Ki67 and H3S10p. mRNA expression of genes involved in cell cycle, metastasis, apoptosis, and oxidative stress were altered by EGb treatment in livers with tumors. Moreover, EGb activated the stress-responsive MAPK pathways in the liver with metastatic tumors. Conclusions: EGb exacerbated liver metastasis in a mouse colon cancer metastasis model. This is potentially due to the increased tumor cell proliferation involving stimulated MAPK pathways.

Original languageEnglish (US)
Article number516
JournalBMC Complementary and Alternative Medicine
Volume17
Issue number1
DOIs
StatePublished - Dec 2 2017

Fingerprint

Ginkgo biloba
Heterografts
Colonic Neoplasms
Neoplasm Metastasis
Liver
Neoplasms
Cell Proliferation
Liver Extracts
Liver Neoplasms
Thyroid Neoplasms
Nude Mice
Cell Cycle
Oxidative Stress
Cardiovascular Diseases
Apoptosis
Staining and Labeling
Gene Expression
Cell Line
Messenger RNA
Injections

Keywords

  • EGb
  • Gene expression
  • Mapk
  • Metastasis
  • Proliferation

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Extract of Ginkgo biloba exacerbates liver metastasis in a mouse colon cancer Xenograft model. / Wang, Huan; Wu, Xia; Lezmi, Stephane; Li, Qian; Helferich, William G.; Xu, Yueqing; Chen, Hong.

In: BMC Complementary and Alternative Medicine, Vol. 17, No. 1, 516, 02.12.2017.

Research output: Contribution to journalArticle

@article{0f7217e488ec4157ae1fa680b7d238c3,
title = "Extract of Ginkgo biloba exacerbates liver metastasis in a mouse colon cancer Xenograft model",
abstract = "Background: Metastasis refers to the spread of a primary tumor cell from the primary site to other locations in the body and it is generally associated with the severity of a tumor. Extract of Ginkgo biloba (EGb) contains various bioactive compounds and it exerts beneficial effects including improvements in brain function and reduced risk of cardiovascular diseases. On the other hand, increased risk of thyroid and liver cancers by EGb have been reported in animals. Methods: A colon cancer metastasis model was established using intrasplenic injection of a human colon cancer cell line, SW620-luc in athymic mice to investigate the potential impact of EGb on colon cancer progression. After tumor establishment, EGb was intraperitonically injected daily for 5 wks. Results: EGb significantly increased the rate of metastasis in mouse liver and decreased the number of necrotic and apoptotic cells in the metastatic liver when compared to the control. Meanwhile, EGb significantly induced proliferation of tumor cells in the metastatic liver, indicated by increased staining of Ki67 and H3S10p. mRNA expression of genes involved in cell cycle, metastasis, apoptosis, and oxidative stress were altered by EGb treatment in livers with tumors. Moreover, EGb activated the stress-responsive MAPK pathways in the liver with metastatic tumors. Conclusions: EGb exacerbated liver metastasis in a mouse colon cancer metastasis model. This is potentially due to the increased tumor cell proliferation involving stimulated MAPK pathways.",
keywords = "EGb, Gene expression, Mapk, Metastasis, Proliferation",
author = "Huan Wang and Xia Wu and Stephane Lezmi and Qian Li and Helferich, {William G.} and Yueqing Xu and Hong Chen",
year = "2017",
month = "12",
day = "2",
doi = "10.1186/s12906-017-2014-7",
language = "English (US)",
volume = "17",
journal = "BMC Complementary and Alternative Medicine",
issn = "1472-6882",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Extract of Ginkgo biloba exacerbates liver metastasis in a mouse colon cancer Xenograft model

AU - Wang, Huan

AU - Wu, Xia

AU - Lezmi, Stephane

AU - Li, Qian

AU - Helferich, William G.

AU - Xu, Yueqing

AU - Chen, Hong

PY - 2017/12/2

Y1 - 2017/12/2

N2 - Background: Metastasis refers to the spread of a primary tumor cell from the primary site to other locations in the body and it is generally associated with the severity of a tumor. Extract of Ginkgo biloba (EGb) contains various bioactive compounds and it exerts beneficial effects including improvements in brain function and reduced risk of cardiovascular diseases. On the other hand, increased risk of thyroid and liver cancers by EGb have been reported in animals. Methods: A colon cancer metastasis model was established using intrasplenic injection of a human colon cancer cell line, SW620-luc in athymic mice to investigate the potential impact of EGb on colon cancer progression. After tumor establishment, EGb was intraperitonically injected daily for 5 wks. Results: EGb significantly increased the rate of metastasis in mouse liver and decreased the number of necrotic and apoptotic cells in the metastatic liver when compared to the control. Meanwhile, EGb significantly induced proliferation of tumor cells in the metastatic liver, indicated by increased staining of Ki67 and H3S10p. mRNA expression of genes involved in cell cycle, metastasis, apoptosis, and oxidative stress were altered by EGb treatment in livers with tumors. Moreover, EGb activated the stress-responsive MAPK pathways in the liver with metastatic tumors. Conclusions: EGb exacerbated liver metastasis in a mouse colon cancer metastasis model. This is potentially due to the increased tumor cell proliferation involving stimulated MAPK pathways.

AB - Background: Metastasis refers to the spread of a primary tumor cell from the primary site to other locations in the body and it is generally associated with the severity of a tumor. Extract of Ginkgo biloba (EGb) contains various bioactive compounds and it exerts beneficial effects including improvements in brain function and reduced risk of cardiovascular diseases. On the other hand, increased risk of thyroid and liver cancers by EGb have been reported in animals. Methods: A colon cancer metastasis model was established using intrasplenic injection of a human colon cancer cell line, SW620-luc in athymic mice to investigate the potential impact of EGb on colon cancer progression. After tumor establishment, EGb was intraperitonically injected daily for 5 wks. Results: EGb significantly increased the rate of metastasis in mouse liver and decreased the number of necrotic and apoptotic cells in the metastatic liver when compared to the control. Meanwhile, EGb significantly induced proliferation of tumor cells in the metastatic liver, indicated by increased staining of Ki67 and H3S10p. mRNA expression of genes involved in cell cycle, metastasis, apoptosis, and oxidative stress were altered by EGb treatment in livers with tumors. Moreover, EGb activated the stress-responsive MAPK pathways in the liver with metastatic tumors. Conclusions: EGb exacerbated liver metastasis in a mouse colon cancer metastasis model. This is potentially due to the increased tumor cell proliferation involving stimulated MAPK pathways.

KW - EGb

KW - Gene expression

KW - Mapk

KW - Metastasis

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=85036537584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036537584&partnerID=8YFLogxK

U2 - 10.1186/s12906-017-2014-7

DO - 10.1186/s12906-017-2014-7

M3 - Article

C2 - 29197355

AN - SCOPUS:85036537584

VL - 17

JO - BMC Complementary and Alternative Medicine

JF - BMC Complementary and Alternative Medicine

SN - 1472-6882

IS - 1

M1 - 516

ER -